COVID-19: Information on ASPIRA LABS Operations

Click to Learn More

News Article

Vermillion to Present at the Canaccord Genuity 2017 Medical Technologies & Diagnostics Forum


AUSTIN, Texas, November 6, 2017 — Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that Valerie Palmieri, President and Chief Executive Officer, will provide a corporate overview at the Canaccord Genuity 2017 Medical Technologies & Diagnostics Forum, being held at the Westin Grand Central Hotel in New York City on November 9, 2017.
Date:               Thursday, November 9
Time:              3:30pm Eastern Time
Location:        Track 5